Brazil issues reminder on import licensing:
This article was originally published in Clinica
Executive Summary
The Brazilian health surveillance agency, Anvisa, has issued a reminder that all imported healthcare products for use in research and clinical trials must receive an import licence before they leave the country of origin. The regulations, set out in Article 62 of Resolution RDC-01 of January 6 2003, seek to ensure that the handling and storage of such products is subject to the quality control criteria of the manufacturer.